Optic neuritis is associated with multiple sclerosis (MS) and is characterized by inflammatory damage to the optic nerve that sends visual signals to the brain. About 20% of people with MS experience optic neuritis as the first symptom, but not all of those with optic neuritis develop MS. Many neurologists consider optic neuritis as an early sign or first warning of the disease. Patients may experience blurred vision, complete loss of sight, a blurry or blind spot in the center of their vision, or color changes. They may also experience pain or flashes of light when moving their eyes.
An antibody analysis has identified two biomarkers that can be used to predict the development of multiple sclerosis (MS) in people with optic neuritis, a study reports. …
Read moreTrethera has been awarded a $1.6 million grant to further develop TRE-515 as a potential treatment for optic neuritis — inflammation of the nerves that transmit data from the eyes to the brain — which also is a…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Trethera Corporation’s experimental oral therapy TRE-515 for demyelinating optic neuritis, an eye condition that may progress to multiple sclerosis (MS) or occur during the…
After a relapse involving optic neuritis, or inflammation in the nerves connecting the eyes and brain, measurements of retinal thinning may predict the likelihood of full recovery from future relapses in people with multiple sclerosis (MS), a study…
As anyone with chronic illness knows, leaving the house requires planning. There’s much more to think about than what’s visible, especially if you’re relying on public transport. In the days preceding last week’s appointment with my multiple sclerosis…
Imagine this scene: There’s a rowdy crowd of nearly 40,000 people in a rugby stadium with music blaring over the Tannoy speakers. Newfound numbness spreads throughout the majority of your body, and on top of that, you can hardly…
In relapsing-remitting MS, relapses and exacerbations involve a worsening of symptoms or the appearance of new ones for 24 hours or more. My disease baseline has changed many times over the years, but has never returned to…
Visual disturbances are common in people with multiple sclerosis (MS), particularly among those with secondary progressive MS (SPMS), longer disease duration, and worse disability status, a new study has found. Yet, “visual complaints may occur in people…
An MS Society survey found that about one-third of people with multiple sclerosis (MS) in the U.K. have kept their condition hidden from their partner, family members, employer, or work colleagues. To help mark MS Awareness…
Endothelin-1 (ET-1) — a molecule with potent blood vessel-narrowing (vasoconstrictive) properties — may be used as a biomarker of severity for optic neuritis in people with multiple sclerosis (MS), a small Italian study suggests. The molecule…
Did you know some of the news and columns on Multiple Sclerosis News Today are recorded and available for listening on SoundCloud? These audio news stories give our readers an alternative option for accessing information important for them.
Get regular updates to your inbox.